IQVIA Holdings Inc. Reports Strong Q2 2026 Financial Performance
IQVIA Holdings Inc., a global leader in healthcare intelligence and clinical research services, has released its financial results for the second quarter of 2026. The company's commitment to transforming the life sciences and healthcare sectors through innovative solutions has propelled it to a remarkable revenue growth trajectory.
1. Overview of Q2 2026 Performance
In Q2 2026, IQVIA reported a revenue increase of $351 million, or 8.7%, compared to the same period in 2025. This remarkable growth was underpinned by strategic initiatives and segment restructuring. The company's revenues for the first half of 2026 reached $5.74 billion, reflecting a year-over-year increase of 8.6%.
Segment Reporting Changes
Effective January 1, 2026, IQVIA restructured its segment reporting, consolidating its previous three segments into two: Commercial Solutions and Research & Development Solutions. This restructuring aligns more closely with industry trends and operational models, thereby enhancing the company's focus on delivering mission-critical information and analytics.
2. Revenue Breakdown by Segment
Commercial Solutions
The Commercial Solutions segment generated revenues of $1,793 million in Q2 2026, which is an 8.6% increase from the previous year. This segment's growth was predominantly driven by strong performance in the Americas, with contributions from Europe and Africa. Revenues for the first half of 2026 reached $3,547 million, showing a 10.1% increase compared to the same period in 2025.
Research & Development Solutions
The Research & Development Solutions segment reported revenues of $2,575 million for Q2 2026, marking an 8.8% increase year-over-year. Notably, this growth was particularly robust in the Europe and Africa regions. The first half of 2026 saw total revenues for this segment reach $4,972 million, representing a 7.5% increase from the previous year.
3. Cost and Expense Analysis
Despite the revenue growth, IQVIA faced increased costs. The cost of revenues (excluding depreciation and amortization) rose by $239 million or 8.9% in Q2 2026, driven largely by higher compensation and reimbursed expenses. Selling, general, and administrative expenses increased by 12.8%, primarily due to rising compensation-related costs.
Income Statement Highlights
Here are some key highlights from the income statement for Q2 2026 compared to Q2 2025:
- Net Income: $256 million (Q2 2025: $266 million)
- Revenue: $4.36 billion (Q2 2025: $4.01 billion)
- Operating Income: $506 million (remained stable compared to the previous year)
| Jul 2025 | Jul 2026 | |
|---|---|---|
Net Income | 1.23B | 1.37B |
Net Income to Non-controlling Interest | 0 | 4M |
Profit | 1.23B | 1.37B |
Net Income Continuing | 1.24B | 1.32B |
Income Tax Expense | 294M | 254M |
Pretax Income | 1.53B | 1.57B |
Non-operating Income | -639M | -626M |
Operating Income | 2.17B | 2.2B |
Revenue | 15.7B | 16.98B |
Costs and Expenses | 13.52B | 14.78B |
Cost of Revenue | 10.32B | 11.38B |
Operating Expenses | 3.19B | 3.39B |
Depreciation, Depletion & Amortization | 1.12B | 1.18B |
Restructuring Charge | 85M | 158M |
Selling, General & Administrative | 1.99B | 2.05B |
4. Backlog and Future Revenue Expectations
The contracted backlog for the Research & Development Solutions segment has shown slight growth, increasing from $34.0 billion at the end of 2025 to $34.2 billion by June 30, 2026. Approximately $9.2 billion of this backlog is expected to convert to revenue within the next twelve months, indicating promising prospects for future revenue.
5. Debt Management and Liquidity
IQVIA's total indebtedness stood at $16.08 billion as of June 30, 2026, with compliance maintained on all debt covenants. The company has been proactive in managing its debt, authorizing an additional $2 billion for its share repurchase program in May 2026, raising the total repurchase authorization to $15.73 billion. In the first half of 2026, IQVIA repurchased 5.5 million shares for $950 million.
Balance Sheet Overview
IQVIA's total assets increased to $29.88 billion in 2026, with total liabilities amounting to $23.58 billion. The total equity stood at $6.30 billion, indicating a solid financial foundation for future growth.
| Jul 2025 | Jul 2026 | |
|---|---|---|
Total Assets | 28.63B | 29.88B |
Total Current Assets | 6.34B | 6.22B |
Cash and Equivalents | 2.03B | 1.90B |
Short-term Investments | 149M | 171M |
Non-trade Receivables | 62M | 42M |
Prepaid Expenses | 200M | 220M |
Other Current Assets | 3.89B | 3.88B |
Total Non-current Assets | 22.28B | 23.65B |
Intangible Assets | 20.20B | 21.35B |
Long-term Investments | 272M | 390M |
Non-current Deferred Tax Assets | 345M | 421M |
Net PP&E | 536M | 547M |
Lease Assets | 280M | 304M |
Other Non-current Assets | 647M | 640M |
Total Liabilities and Equity | 28.63B | 29.88B |
Total Liabilities | 22.84B | 23.58B |
Total Current Liabilities | 7.57B | 8.81B |
Accounts Payable and Accrued Liabilities | 3.52B | 3.78B |
Current Debt | 1.31B | 2.29B |
Current Deferred Revenue | 2.12B | 2.28B |
Other Current Liabilities | 613M | 457M |
Total Non-current Liabilities | 15.27B | 14.76B |
Long-term Debt | 14.17B | 13.70B |
Non-current Deferred Tax Liabilities | 216M | 173M |
Other Non-current Liabilities | 881M | 887M |
Total Equity and Non-controlling Interests | 5.78B | 6.30B |
Total Equity | 5.77B | 6.17B |
Non-controlling Interests | 8M | 130M |
6. Cash Flow Analysis
In terms of cash flow, IQVIA reported a net change in cash of -$38 million for the second quarter. This was impacted by significant cash outflows for investing and financing activities, including share repurchases and payments for productive assets.
| Jul 2025 | Jul 2026 | |
|---|---|---|
Net Change in Cash | 494M | -130M |
Effect of Exchange Rate Changes | 62M | -34M |
Net Cash from Operating Activities | 2.61B | 2.81B |
Operating Profit | 1.23B | 1.37B |
Adjustment to Operating Profit | 1.38B | 1.44B |
Net Cash from Investing Activities | -1.56B | -2.23B |
Business & Interest in Affiliates | 939M | 1.67B |
Investments | 17M | -2M |
Productive Assets | 607M | 560M |
Other Investing Activities | 3M | 1M |
Net Cash from Financing Activities | -625M | -684M |
Debt | 1.86B | 615M |
Equity Issuance/Repurchase | -2.34B | -1.08B |
Other Financing Activities | -151M | -210M |
7. Conclusion
IQVIA Holdings Inc. is navigating a dynamic environment with strategic restructuring, robust revenue growth, and effective debt management. The company's focus on enhancing its service offerings and operational efficiency positions it well to capitalize on future opportunities within the life sciences and healthcare sectors. As IQVIA continues to leverage its Connected Intelligence platform, stakeholders can look forward to sustained growth and innovation in the months ahead.
